Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients

Hepatology International

Volumn 5, Issue 2, 2011, Pages 681-687

  Bouzgarrou, Nadia ^a   Hassen, Elham ^a   Bahri, Olfa ^b   Gabbouj, Sallouha ^a   Mami, Nabil Ben ^c   Triki, Henda ^b   Chouchane, Lotfi ^a,d  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Cirrhosis; Combined analysis; Cytokine; Hepatitis C; Polymorphism

Indexed keywords

ADENOSINE; CYTIDINE; GUANOSINE; THYMIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA INTERFERON GENE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INHERITANCE; INTERLEUKIN 10 GENE; INTERLEUKIN 18 GENE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

EID: 79956273892     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-010-9232-0     Document Type: Article

References (63)

1. CL Thio DL Thomas M Carrington 2000 Chronic viral hepatitis and the human genome Hepatology 31 819 827 10733534 10.1053/he.2000.4316 1:CAS:528: DC%2BD3cXis1Cksrw%3D (Pubitemid 30169925)
2. A Bertoletti C Ferrari 2003 Kinetics of the immune response during HBV and HCV infection Hepatology 38 4 13 12829979 10.1053/jhep.2003.50310 1:CAS:528:DC%2BD3sXlvFajurw%3D (Pubitemid 36775788)
3. CL Thio 2008 Host genetic factors and antiviral immune responses to hepatitis C virus Clin Liver Dis 12 713 726 18625436 10.1016/j.cld.2008.03.002 (Pubitemid 351952476)
4. ME Cramp P Carucci S Rossol S Chokshi G Maertens R Williams, et al. 1999 Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia Gut 44 424 429 10026332 10.1136/gut.44.3.424 1:STN:280:DyaK1M7lt1Wnsg%3D%3D (Pubitemid 29119342)
5. GR Pape TJ Gerlach HM Diepolder N Grüner M Jung T Santantonio 1999 Role of the specific T-cell response for clearance and control of hepatitis C virus J Viral Hepat 6 36 40 10760033 10.1046/j.1365-2893.1999.00006.x (Pubitemid 29349787)
6. RT Marinho R Pinto ML Santos IV Lobos MC Moura 2004 Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C J Viral Hepat 11 206 216 15117322 10.1111/j.1365-2893.2004.00496.x 1:STN:280:DC%2BD2c3itVWrtA%3D%3D (Pubitemid 38658445)
7. Y Kawakami S Nabeshima N Furusyo Y Sawayama J Hayashi S Kashiwagi 2000 Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection Am J Gastroenterol 95 3670 3673
8. J Napoli GA Bishop PH McGuinness DM Painter GW McCaughan 1996 Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines Hepatology 24 759 765 8855173 10.1002/hep.510240402 1:STN:280:DyaK2s%2Fgsl2itg%3D%3D (Pubitemid 26334270)
9. S Sobue T Nomura T Ishikawa S Ito K Saso H Ohara, et al. 2001 Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection J Gastroenterol 36 544 551 11519833 10.1007/s005350170057 1:CAS:528:DC%2BD3MXmsVOgtrg%3D (Pubitemid 32791841)
10. K Falasca C Ucciferri M Dalessandro P Zingariello P Mancino C Petrarca E Pizzigallo P Conti J Vecchiet 2006 Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C Ann Clin Lab Sci 36 144 150 16682509 1:CAS:528:DC%2BD28XlvVSlsrs%3D
11. E Gigi M Raptopoulou-Gigi A Kalogeridis S Masiou E Orphanou E Vrettou TH Lalla E Sinakos V Tsapas 2008 Cytokine mRNA expression in hepatitis C virus infection: Th1 predominance in patients with chronic hepatitis C and Th1-Th2 cytokine profile in subjects with self-limited disease J Viral Hepat 15 145 154 18184198 1:STN:280:DC%2BD1c%2Fit1agsw%3D%3D
12. R Bataller DA Brenner 2005 Liver fibrosis J Clin Invest 115 209 218 15690074 1:CAS:528:DC%2BD2MXhtFyjs70%3D (Pubitemid 40385459)
13. TA Wynn 2008 Cellular and molecular mechanisms of fibrosis J Pathol 214 199 210 18161745 10.1002/path.2277 1:CAS:528:DC%2BD1cXhvFCkt7w%3D (Pubitemid 351160157)
14. S Sobue T Nomura T Ishikawa S Ito K Saso H Ohara T Joh M Itoh S Kakumu 2001 Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection J Gastroenterol 36 544 551 11519833 10.1007/s005350170057 1:CAS:528:DC%2BD3MXmsVOgtrg%3D (Pubitemid 32791841)
15. S Mihm A Hutschenreiter A Fayyazi S Pingel G Ramadori 1996 High inflammatory activity is associated with an increased amount of IFNgamma transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection Med Microbiol Immunol 185 95 102 8884741 10.1007/s004300050020 1:STN:280:DyaK2s%2FjvFWlsg%3D%3D (Pubitemid 26302541)
16. A Bertoletti MM D'Elios C Boni M De Carli AL Zignego M Durazzo G Missale A Penna F Fiaccadori G Del Prete C Ferrari 1997 Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections Gastroenterology 112 193 199 8978359 10.1016/S0016-5085(97)70235-X 1:STN:280:DyaK2s7jtlSjsg%3D%3D (Pubitemid 27009002)
17. LJ Zhang XZ Wang 2006 Interleukin-10 and chronic liver disease World J Gastroenterol 12 1681 1685 16586534 1:CAS:528:DC%2BD28XkvVaks7k%3D
18. H Louis JL Van Laethem W Wu E Quertinmont C Degraef K Van den Berg A Demols M Goldman O Le Moine A Geerts J Devière 1998 Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice Hepatology 28 1607 1615 9828225 10.1002/hep.510280621 1:CAS:528:DyaK1cXotFSgt74%3D (Pubitemid 28549131)
19. DR Nelson GY Lauwers JY Lau GL Davis 2000 Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders Gastroenterology 118 655 660 10734016 10.1016/S0016-5085(00)70134-X 1:CAS:528:DC%2BD3cXis1ensrc%3D (Pubitemid 30171614)
20. DR Nelson Z Tu C Soldevila-Pico M Abdelmalek H Zhu YL Xu, et al. 2003 Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect Hepatology 38 859 868 14512873 1:CAS:528: DC%2BD3sXovFGhtb0%3D (Pubitemid 37221669)
21. TA Fehniger MH Shah MJ Turner JB VanDeusen SP Whitman MA Cooper Wechser M SuzukiK F Goodsaid MA Caligiuri 1999 Differential cytokine and chemiokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implication for the innate immune response J Immunol 162 4511 4520 10201989 1:CAS:528:DyaK1MXisFOms7Y%3D (Pubitemid 29314849)
22. AJ Puren G Fantuzzi Y Gu MS Su CA Dinarello 1999 Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNF-alpha production from non-CD14p human blood mononuclear cells J Clin Invest 101 711 10.1172/JCI1379
23. PH McGuinness D Painter S Davies GW McCaughan 2000 Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronichepatitis C infection Gut 46 260 269 10644323 10.1136/gut.46.2.260 1:CAS:528:DC%2BD3cXhtFyrtbo%3D (Pubitemid 30305855)
24. MG Neuman JP Benhamou P Marcellin D Valla IM Malkiewicz GG Katz C Trepo M Bourliere RG Cameron L Cohen M Morgan H Schmilovitz-Weiss Z Ben-Ari 2007 Cytokine-chemokine and apoptotic signatures in patients with hepatitis C Transl Res 149 126 136 17320798 10.1016/j.trsl.2006.11.002 1:CAS:528: DC%2BD2sXitFCisb4%3D
25. N Bouzgarrou E Hassen E Schvoerer F Stoll-Keller O Bahri S Gabbouj I Cheikh N Maamouri N Mammi H Saffar A Trabelsi H Triki L Chouchane 2008 Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection J Med Virol 80 607 614 18297714 10.1002/jmv.21079 1:CAS:528:DC%2BD1cXktFaksrc%3D (Pubitemid 351358557)
26. A Sharma A Chakraborti A Das RK Dhiman Y Chawla 2009 Elevation of interleukin-18 in chronic hepatitis C: Implications for hepatitis C virus pathogenesis Immunology 128 1 Suppl e514 e522 19740312 10.1111/j.1365-2567.2008. 03021.x
27. WE Ollier 2004 Cytokine genes and disease susceptibility Cytokine 28 174 178 15588692 10.1016/j.cyto.2004.07.014 1:CAS:528:DC%2BD2cXhtVaqsbrL (Pubitemid 39573505)
28. CY Dai WL Chuang LP Lee SC Chen NJ Hou ZY Lin MY Hsieh MY Hsieh LY Wang WY Chang ML Yu 2006 Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C J Viral Hepat 13 770 774 17052277 10.1111/j.1365-2893.2006.00767.x (Pubitemid 44583503)
29. QJ Gao DW Liu SY Zhang M Jia LM Wang LH Wu SY Wang LX Tong 2009 Polymorphisms of some cytokines and chronic hepatitis B and C virus infection World J Gastroenterol 15 5610 5619 19938203 10.3748/wjg.15.5610 1:CAS:528:DC%2BD1MXhsFSmtbvI
30. K Manohar PV Suneetha Pati NT Sukriti AC Gupta S Hissar P Sakhuja SK Sarin 2009 Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients Hepatol Int 3 371 377 19669363 10.1007/s12072-009-9127-0 1:STN:280:DC%2BD1Mrks1GltA%3D%3D
31. N Paladino H Fainboim G Theiler T Schroder AE Muñoz AC Flores O Galdame L Fainboim 2006 Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism J Virol 80 9144 9150 16940525 10.1128/JVI.00339-06 1:CAS:528:DC%2BD28XpvVGhsrc%3D (Pubitemid 44359986)
32. M Persico M Capasso E Persico M Masarone A Renzo D Spano S Bruno A Iolascon 2006 Interleukin-10 -1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection J Hepatol 45 779 785 17049666 10.1016/j.jhep.2006.07.026 1:CAS:528:DC%2BD28XhtFeqtLrN (Pubitemid 44646685)
33. DL Thomas CL Thio MP Martin Y Qi D Ge C O'Huigin J Kidd K Kidd SI Khakoo G Alexander JJ Goedert GD Kirk SM Donfield HR Rosen LH Tobler MP Busch JG McHutchison DB Goldstein M Carrington 2009 Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 798 801 19759533 10.1038/nature08463 1:CAS:528:DC%2BD1MXhtFentb%2FJ
34. N Bouzgarrou E Hassen K Farhat O Bahri S Gabbouj N Maamouri N Ben Mami H Saffar A Trabelsi H Triki L Chouchane 2009 Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity Hum Immunol 70 230 236 19480854 10.1016/j.humimm.2009.01.019 1:CAS:528: DC%2BD1MXjslyju7c%3D
35. CY Dai WL Chuang MY Hsieh LP Lee NJ Hou SC Chen, et al. 2006 Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C Transl Res 148 128 133 16938650 10.1016/j.trsl.2006.04.005 1:CAS:528:DC%2BD28XhtFWjsrrM (Pubitemid 44287635)
36. S Barrett M Collins C Kenny E Ryan CO Keane J Crowe 2003 Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection J Med Virol 71 212 218 12938195 10.1002/jmv.10472 1:CAS:528:DC%2BD3sXnsleitrg%3D (Pubitemid 37048464)
37. Z Abbas T Moatter A Hussainy W Jafri 2005 Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3 World J Gastroenterol 11 6656 6661 16425360 (Pubitemid 43072706)
38. JC Machado C Figueiredo P Canedo P Pharoah R Carvalho S Nabais C Castro Alves ML Campos LJ Van Doorn C Caldas R Seruca F Carneiro M Sobrinho- Simões 2003 A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma Gastroenterology 125 364 371 12891537 10.1016/S0016-5085(03)00899-0 1:CAS:528:DC%2BD3sXmvFygu70%3D (Pubitemid 36929416)
39. MM Richardson EE Powell HD Barrie AD Clouston DM Purdie JR Jonsson 2005 A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C J Med Genet 42 e45 15994870 10.1136/jmg.2005.032557 1:STN:280:DC%2BD2MzktlWlug%3D%3D
40. L Beretta F Cappiello JH Moore M Barili CS Greene R Scorza 2008 Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients Arthritis Rheum 59 974 983 18576303 10.1002/art.23836 1:CAS:528:DC%2BD1cXpt1egtLk%3D (Pubitemid 351990994)
41. DQ Chen Y Zeng J Zhou L Yang S Jiang JD Huang L Lu BJ Zheng 2010 Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population J Med Virol 82 371 378 20087947 10.1002/jmv.21716 1:CAS:528:DC%2BC3cXitlKntrc%3D
42. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 3344216 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D
43. CG Mullighan SE Marshall M Bunce KI Welsh 1999 Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency Genes Immun 1 137 148 11196660 10.1038/sj.gene.6363653 1:CAS:528:DC%2BD3cXktlyhu78%3D (Pubitemid 129627291)
44. V Pravica C Perrey A Stevens JH Lee IV Hutchinson 2000 A single nucleotide polymorphism in the first intron of the human IFNgamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFNgamma production Hum Immunol 61 863 866 11053629 10.1016/S0198-8859(00)00167-1 1:CAS:528:DC%2BD3cXosVWlu7s%3D
45. N Boyer P Marcellin 2000 Pathogenesis, diagnosis and management of hepatitis C J Hepatol 32 98 112 10728798 10.1016/S0168-8278(00)80419-5 1:STN:280:DC%2BD3c7ptFWnsA%3D%3D (Pubitemid 30123628)
46. B Rehermann M Nascimbeni 2005 Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 215 229 15738952 10.1038/nri1573 1:CAS:528:DC%2BD2MXhslSju7k%3D (Pubitemid 40364823)
47. M Levrero 2006 Viral hepatitis and liver cancer: The case of hepatitis C Oncogene 25 3834 3847 16799625 10.1038/sj.onc.1209562 1:CAS:528: DC%2BD28XmtFCntLc%3D (Pubitemid 43980479)
48. XH Wang DM Netski J Astemborski SH Mehta MS Torbenson DL Thomas SC Ray 2007 Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution J Virol 81 6513 6522 17329332 10.1128/JVI.02276-06 1:CAS:528:DC%2BD2sXmt1Orsbo%3D (Pubitemid 46878056)
49. SX Hu NL Kyulo VW Xia DJ Hillebrand KQ Hu 2009 Factors associated with hepatic fibrosis in patients with chronic hepatitis C: A retrospective study of a large cohort of U.S. patients J Clin Gastroenterol 43 758 764 19238091 10.1097/MCG.0b013e31818be17c 1:CAS:528:DC%2BD1MXhtVWkur%2FM
50. M Yamada S Kakumu K Yoshioka Y Higashi K Tanaka T Ishikawa, et al. 1994 Hepatitis C virus genotypes are not responsible for development of serious liver disease Dig Dis Sci 39 234 239 8313803 10.1007/BF02090191 1:CAS:528: DyaK2MXpt1am (Pubitemid 24073594)
51. PH McGuinness GA Bishop DM Painter R Chan GW McCaughan 1996 Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C Hepatology 23 676 687 8666317 10.1002/hep.510230404 1:CAS:528:DyaK28XisFygsbY%3D (Pubitemid 26111977)
52. K Yoshizawa M Ota S Saito A Maruyama T Yamaura A Rokuhara K Orii T Ichijo A Matsumoto E Tanaka K Kiyosawa 2003 Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease Tissue Antigens 61 159 165 12694584 10.1034/j.1399-0039.2003.00015.x 1:CAS:528:DC%2BD3sXjvVSjtLw%3D (Pubitemid 36549602)
53. GS Baroni A Pastorelli A Manzin A Benedetti L Marucci L Solforosi A Di Sario E Brunelli F Orlandi M Clementi G Macarri 1999 Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C Liver 19 212 219 10395041 10.1111/j.1478-3231.1999.tb00038.x 1:STN:280:DyaK1MzitV2ltg%3D%3D (Pubitemid 29261588)
54. CC Chen SY Yang CJ Liu CL Lin YF Liaw SM Lin SD Lee PJ Chen CJ Chen MW Yu 2005 Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma Int J Epidemiol 34 1310 1318 16172101 10.1093/ije/dyi191 (Pubitemid 41819538)
55. S Sfar H Saad F Mosbah L Chouchane 2009 Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness Mol Biol Rep 36 37 45 17917789 10.1007/s11033-007-9149-4 1:CAS:528:DC%2BD1cXhtl2mu7rO
56. TS Ahluwalia M Khullar M Ahuja HS Kohli A Bhansali V Mohan R Venkatesan TS Rai K Sud PK Singal 2009 Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians PLoS One 4 e5168 19357773 10.1371/journal.pone.0005168
57. KW Moore R de Waal Malefyt RL Coffman A O'Garra 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 11244051 10.1146/annurev.immunol.19.1.683 1:CAS:528:DC%2BD3MXivFKgu70%3D (Pubitemid 32368050)
58. KN Couper DG Blount EM Riley 2008 IL-10: the master regulator of immunity to infection J Immunol 180 9 5771 5777 18424693 1:CAS:528:DC%2BD1cXkvVequ7o%3D
59. E Crawley R Kay J Sillibourne P Patel I Hutchinson P Woo 1999 Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 1101 1108 10366102 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y 1:CAS:528:DyaK1MXktVegt70%3D (Pubitemid 29268946)
60. V Yilmaz SP Yentur G Saruhan-Direskeneli 2005 IL-12 and IL-10 polymorphisms and their effects on cytokine production Cytokine 30 188 194 15863393 10.1016/j.cyto.2005.01.006 1:CAS:528:DC%2BD2MXjvVKrt7s%3D (Pubitemid 40615967)
61. SA Stanilova LD Miteva ZT Karakolev CS Stefanov 2006 Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility Intensive Care Med 32 260 266 16435103 10.1007/s00134-005-0022-4 1:CAS:528:DC%2BD28XhtFSjsr3P (Pubitemid 43251147)
62. L Miteva S Stanilova 2008 The combined effect of interleukin (IL)-10 and IL-12 polymorphisms on induced cytokine production Hum Immunol 69 562 566 18703108 10.1016/j.humimm.2008.07.008 1:CAS:528:DC%2BD1cXhtFWmu7jM
63. FB Qiu LQ Wu Y Lu S Zhang BY Zhang 2007 Predominant expression of Th1-type cytokines in primary hepatic cancer and adjacent liver tissues Hepatobiliary Pancreat Dis Int 6 63 66 17287169 1:CAS:528:DC%2BD2sXislCnt7w%3D (Pubitemid 46243163)